Philippe Drevot
Clinical Development and Project Director
Pharmacist and PhD in immunology with 20 years of experience in clinical operations and development, Philippe has managed global studies in oncology and neuropediatric rare disease indications in North America, South America, South East Asia and Eastern Europe.
He manages studies from start-up to close out, including the writing of essential documents (investigators brochure, clinical trial protocol, ICF, study plans) and the management of third-party vendors.
Before joining ILife Consulting in March 2024, Philippe was Head of Clinical Operations at Lysogene.
His current responsibilities include:
-
Management of project resource attribution and project delivery
-
Management of Clinical Project Managers
-
Assisting biotechs with clinical development, communication, financial and operational strategies
Experience
-
Phase III Oncology – Chemotherapy and mAb (Adjuvant breast cancer, Metastatic breast cancer)
-
Phase II/III Neuropediatric rare disease - Gene therapy (Sanfilippo A)
-
Phase I/II Neuropediatric rare disease - Gene therapy (Gangliosidosis)